Literature DB >> 18562457

The cost of Child Health Days: a case study of Ethiopia's Enhanced Outreach Strategy (EOS).

John L Fiedler1, Tesfaye Chuko.   

Abstract

Child Health Days (CHDs) are twice-annual campaign-style events designed to increase the coverage of vitamin A and one or more other child health services. Although more than two dozen countries have had a CHD, little has been published about them. This paper presents an activity-based costing study of Ethiopia's version of CHDs, the Enhanced Outreach Strategy (EOS). The December 2006 round reached more than 10 million beneficiaries at an average cost per beneficiary of US$0.56. When measles is added, the cost of the package doubles. Given the way the distribution day delivery system and the service package are structured, there are economies of scope. Because most of the costs are determined by the number of delivery sites and are independent of the number of beneficiaries, other things equal, increasing the beneficiaries would reduce the average cost per beneficiary. Taking into account only the mortality impact of vitamin A, EOS saved 20,200 lives and averted 230,000 DALYs of children 6-59 months. The average cost per life saved was US$228 and the cost per DALY averted was equivalent to 6% of per capita GDP (US$9), making the EOS cost-effective, according to WHO criteria. While CHDs are generally construed as a temporary strategy for improving coverage of supply-constrained systems, inadequate attention has been paid to demand-side considerations that suggest CHDs have an important role to play in changing care-seeking behaviour, in increasing community organization and participation, and in promoting district autonomy and capacity. Recognition of these effects suggests the need for decisions about where and when to introduce, and when to end, a CHD to take into account more than 'just' health sector considerations: they are more broadly about community development. UNICEF played a key role in initiating the EOS and finances 68% of costs, raising concern about the programme's long-term sustainability.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18562457     DOI: 10.1093/heapol/czn015

Source DB:  PubMed          Journal:  Health Policy Plan        ISSN: 0268-1080            Impact factor:   3.344


  16 in total

1.  Economic Evaluations of Child Nutrition Interventions in Low- and Middle-Income Countries: Systematic Review and Quality Appraisal.

Authors:  Yeji Baek; Zanfina Ademi; Susan Paudel; Jane Fisher; Thach Tran; Lorena Romero; Alice Owen
Journal:  Adv Nutr       Date:  2022-02-01       Impact factor: 11.567

2.  Scale up of nutrition and health programs in Ethiopia and their overlap with reductions in child stunting.

Authors:  James P Wirth; Joan Matji; Bradley A Woodruff; Sylvie Chamois; Zewditu Getahun; Jessica M White; Fabian Rohner
Journal:  Matern Child Nutr       Date:  2016-05-01       Impact factor: 3.092

3.  Modeling the economic and epidemiologic impact of hookworm vaccine and mass drug administration (MDA) in Brazil, a high transmission setting.

Authors:  Sarah M Bartsch; Peter J Hotez; Daniel L Hertenstein; David J Diemert; Kristina M Zapf; Maria Elena Bottazzi; Jeffrey M Bethony; Shawn T Brown; Bruce Y Lee
Journal:  Vaccine       Date:  2016-03-18       Impact factor: 3.641

4.  Cost analysis of school-based intermittent screening and treatment of malaria in Kenya.

Authors:  Thomas L Drake; George Okello; Kiambo Njagi; Katherine E Halliday; Matthew Ch Jukes; Lindsay Mangham; Simon Brooker
Journal:  Malar J       Date:  2011-09-20       Impact factor: 2.979

5.  Screening for acute childhood malnutrition during the National Nutrition Week in mali increases treatment referrals.

Authors:  Daniele H Nyirandutiye; Akory Ag Iknane; Amadou Fofana; Kenneth H Brown
Journal:  PLoS One       Date:  2011-06-23       Impact factor: 3.240

Review 6.  Cost and cost-effectiveness of soil-transmitted helminth treatment programmes: systematic review and research needs.

Authors:  Hugo C Turner; James E Truscott; T Déirdre Hollingsworth; Alison A Bettis; Simon J Brooker; Roy M Anderson
Journal:  Parasit Vectors       Date:  2015-07-03       Impact factor: 3.876

7.  Updating the evidence base on the operational costs of supplementary immunization activities for current and future accelerated disease control, elimination and eradication efforts.

Authors:  Gian Gandhi; Patrick Lydon
Journal:  BMC Public Health       Date:  2014-01-22       Impact factor: 3.295

8.  The costs and cost-effectiveness of mass treatment for intestinal nematode worm infections using different treatment thresholds.

Authors:  Andrew Hall; Sue Horton; Nilanthi de Silva
Journal:  PLoS Negl Trop Dis       Date:  2009-03-31

9.  Intestinal parasite prevalence in an area of ethiopia after implementing the SAFE strategy, enhanced outreach services, and health extension program.

Authors:  Jonathan D King; Tekola Endeshaw; Elisabeth Escher; Genetu Alemtaye; Sileabatt Melaku; Woyneshet Gelaye; Abebe Worku; Mitku Adugna; Berhanu Melak; Tesfaye Teferi; Mulat Zerihun; Demelash Gesese; Zerihun Tadesse; Aryc W Mosher; Peter Odermatt; Jürg Utzinger; Hanspeter Marti; Jeremiah Ngondi; Donald R Hopkins; Paul M Emerson
Journal:  PLoS Negl Trop Dis       Date:  2013-06-06

10.  Supplementary immunization activities (SIAs) in South Africa: comprehensive economic evaluation of an integrated child health delivery platform.

Authors:  Stéphane Verguet; Waasila Jassat; Melanie Y Bertram; Stephen M Tollman; Christopher J L Murray; Dean T Jamison; Karen J Hofman
Journal:  Glob Health Action       Date:  2013-03-01       Impact factor: 2.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.